I undersøgelsen hos børn var reduktionen af den ugentlige anfaldshyppighed 43, 3% i Keppra- gruppen og 16, 3% i placebo- gruppen.
In the study in children, the reduction in weekly seizure rate was 43.3% in the group of children who received Keppra, and 16.3% in the placebo group.